Zeng-Fu Shang (Ji Zhu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Venues

Nature communications

International journal of cancer

Cancers

Cell death discovery

Fudan University Shanghai Cancer Center

Fudan University Shanghai Cancer Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University Shanghai Cancer Center Jul 01 2000

China

Professor :: Department of Radiation Oncology

Education History

Fudan University Shanghai Cancer Center Sep 01 2006 - Jun 30 2009

China

PHD :: Department of Radiation Oncology

Publications

Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Publisher Correction: Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 14 (1) (2023)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Publisher Correction: Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 14 (1) (2023)
Pei-Cheng Jiang, Shuo-Wen Wang, Chao Li, Jin Fan, Zeng-Fu Shang
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration. International journal of cancer 154 (8) (2023)
Xiaoqing Li, Dexuan Gao, Fei Shen, Hengrui Chen, Zhuqiang Zhang, Chao He, Aidi Gao, Yue Lang, Xiaozhong Zhu, Zeng-Fu Shang, Zeng-Fu Shang, Wei-Qun Ding, Jundong Zhou
Polymerase iota (POLI) confers radioresistance of esophageal squamous cell carcinoma by regulating RAD51 stability and facilitating homologous recombination. Cell death discovery 9 (1) (2023)
Pei-Cheng Jiang, Shuo-Wen Wang, Chao Li, Jin Fan, Zeng-Fu Shang
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration. International journal of cancer 154 (8) (2023)
Pei-Cheng Jiang, Shuo-Wen Wang, Chao Li, Jin Fan, Zeng-Fu Shang
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration. International journal of cancer (2023)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Hongmiao Wang, Huixun Jia, Yang Gao, Haosong Zhang, Jin Fan, Lijie Zhang, Fandong Ren, Yandong Yin, Yuping Cai, Zeng-Fu Shang, Zheng-Jiang Zhu
Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nature communications 13 (1) (2022)
Yaqi Wang, Lifeng Yang, Hua Bao, Xiaojun Fan, Fan Xia, Juefeng Wan, Lijun Shen, Yun Guan, Hairong Bao, Xue Wu, Yang Xu, Yang W Shao, Yiqun Sun, Tong Tong, Xinxiang Li, Ye Xu, Sanjun Cai, Zeng-Fu Shang, Zhen Zhang
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study. PLoS medicine 18 (8) (2021)
Zeng-Fu Shang, Anwen Liu, Xinchen Sun, Luying Liu, Yaqun Zhu, Tao Zhang, Jianhui Jia, Shisheng Tan, Junxin Wu, Xin Wang, Juying Zhou, Jialin Yang, Chen Zhang, Hongyan Zhang, Yuanyuan Zhao, Gang Cai, Wei Zhang, Fan Xia, Juefeng Wan, Hui Zhang, Lijun Shen, SanJun Cai, Zhen Zhang
Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Jinming Fu, Zeng-Fu Shang, Fenqi Du, Lijie Zhang, Dapeng Li, Hao Huang, Tian Tian, Yupeng Liu, Lei Zhang, Ying Liu, Yuanyuan Zhang, Jing Xu, Shuhan Meng, Chenyang Jia, Simin Sun, Xue Li, Liyuan Zhao, Ding Zhang, Lixin Kang, Lijing Gao, Ting Zheng, Sanjun Cai, Yanlong Liu, Yashuang Zhao
Prognostic Inflammatory Index Based on Preoperative Peripheral Blood for Predicting the Prognosis of Colorectal Cancer Patients. Cancers 13 (1) (2020)
Yun Guan, Yunzhu Shen, Ye Xu, Chao Li, Jingwen Wang, Weilie Gu, Peng Lian, Dan Huang, Sanjun Cai, Zhen Zhang, Zeng-Fu Shang
An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype. Therapeutic advances in gastroenterology 12 (2019)
Jingwen Wang, Yun Guan, Weilie Gu, Senxiang Yan, Juying Zhou, Dan Huang, Tong Tong, Chao Li, Sanjun Cai, Zhen Zhang, Zeng-Fu Shang
Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002). Radiation oncology (London, England) 14 (1) (2019)

Zeng-Fu Shang.css-eqlu8i{font-size:small;padding-left:4px;} (Ji Zhu)

Publication Activity (10 Years)

Top Topics

Top Venues

Zeng-Fu Shang (Ji Zhu)